{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:51:08Z","timestamp":1774288268134,"version":"3.50.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T00:00:00Z","timestamp":1533859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0202045","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T17:31:57Z","timestamp":1533922317000},"page":"e0202045","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9829-1309","authenticated-orcid":true,"given":"Normann","family":"Steiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Hajek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7194-6771","authenticated-orcid":true,"given":"Sabina","family":"Sevcikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojana","family":"Borjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"J\u00f6hrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"G\u00f6bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Pircher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberhard","family":"Gunsilius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,8,10]]},"reference":[{"issue":"20","key":"ref1","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1182\/blood-2014-09-568899","article-title":"Smoldering multiple myeloma","volume":"125","author":"SV Rajkumar","year":"2015","journal-title":"Blood"},{"issue":"9983","key":"ref2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(14)60493-1","article-title":"Multiple myeloma","volume":"385","author":"C Rollig","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"20","key":"ref3","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1182\/blood-2014-11-568923","article-title":"Treatment options for relapsed and refractory multiple myeloma","volume":"125","author":"AK Nooka","year":"2015","journal-title":"Blood"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"NN Pavlova","year":"2016","journal-title":"Cell metabolism"},{"issue":"5930","key":"ref5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"MG Vander Heiden","year":"2009","journal-title":"Science (New York, NY)"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/metabo3030552","article-title":"A review of applications of metabolomics in cancer","volume":"3","author":"RD Beger","year":"2013","journal-title":"Metabolites"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.15252\/emmm.201606798","article-title":"Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities","volume":"8","author":"J Goveia","year":"2016","journal-title":"EMBO molecular medicine"},{"issue":"30","key":"ref8","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1038\/onc.2015.464","article-title":"Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax","volume":"35","author":"R Bajpai","year":"2016","journal-title":"Oncogene"},{"issue":"17","key":"ref9","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1158\/1078-0432.CCR-12-2917","article-title":"Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission","volume":"19","author":"L Puchades-Carrasco","year":"2013","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1158\/0008-5472.CAN-14-3400","article-title":"Metabolic signature identifies novel targets for drug resistance in multiple myeloma","volume":"75","author":"P Maiso","year":"2015","journal-title":"Cancer research"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1038\/bcj.2015.85","article-title":"Alterations in bone marrow metabolism are an early and consistent feature during the development of MGUS and multiple myeloma","volume":"5","author":"C Ludwig","year":"2015","journal-title":"Blood cancer journal"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"IMW Group","year":"2003","journal-title":"British journal of haematology"},{"issue":"24","key":"ref13","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1002\/elps.201500352","article-title":"Missing value imputation strategies for metabolomics data","volume":"36","author":"EG Armitage","year":"2015","journal-title":"Electrophoresis"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.lungcan.2009.05.001","article-title":"Increased serum kynurenine\/tryptophan ratio correlates with disease progression in lung cancer","volume":"67","author":"Y Suzuki","year":"2010","journal-title":"Lung cancer (Amsterdam, Netherlands)"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1182\/blood-2008-07-144485","article-title":"The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology","volume":"113","author":"A Curti","year":"2009","journal-title":"Blood"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1038\/leu.2017.102","article-title":"Proteomic characterization of human multiple myeloma bone marrow extracellular matrix","volume":"31","author":"SV Glavey","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0167-4838(01)00147-9","article-title":"Molecular enzymology of carnitine transfer and transport","volume":"1546","author":"RR Ramsay","year":"2001","journal-title":"Biochimica et biophysica acta"},{"issue":"7655","key":"ref18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature22314","article-title":"Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia","volume":"545","author":"A Hattori","year":"2017","journal-title":"Nature"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1158\/0008-5472.CAN-17-0165","article-title":"Nature and Nurture: What Determines Tumor Metabolic Phenotypes?","volume":"77","author":"JR Mayers","year":"2017","journal-title":"Cancer research"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nm.3217","article-title":"BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1","volume":"19","author":"M Tonjes","year":"2013","journal-title":"Nature medicine"},{"issue":"7639","key":"ref21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature21052","article-title":"Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer","volume":"542","author":"P Dey","year":"2017","journal-title":"Nature"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/liv.13178","article-title":"BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin","volume":"36","author":"YH Zheng","year":"2016","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"issue":"31","key":"ref23","doi-asserted-by":"crossref","first-page":"31522","DOI":"10.18632\/oncotarget.5159","article-title":"BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism","volume":"6","author":"ZQ Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbrc.2017.02.101","article-title":"Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function","volume":"486","author":"L Zhang","year":"2017","journal-title":"Biochemical and biophysical research communications"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40170-017-0169-9","article-title":"Bortezomib resistance in multiple myeloma is associated with increased serine synthesis","volume":"5","author":"EA Zaal","year":"2017","journal-title":"Cancer & metabolism"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40425-015-0094-9","article-title":"Targeting the indoleamine 2,3-dioxygenase pathway in cancer","volume":"3","author":"YW Moon","year":"2015","journal-title":"Journal for immunotherapy of cancer"},{"issue":"6\u20137","key":"ref27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3109\/08820139.2012.689405","article-title":"Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance","volume":"41","author":"TS Johnson","year":"2012","journal-title":"Immunological investigations"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.18632\/oncotarget.6467","article-title":"Understanding the role of the kynurenine pathway in human breast cancer immunobiology","volume":"7","author":"B Heng","year":"2016","journal-title":"Oncotarget"},{"issue":"7368","key":"ref29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"CA Opitz","year":"2011","journal-title":"Nature"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00262-014-1549-4","article-title":"Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer","volume":"63","author":"GC Prendergast","year":"2014","journal-title":"Cancer immunology, immunotherapy: CII"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"C Uyttenhove","year":"2003","journal-title":"Nature medicine"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7150\/ijbs.6426","article-title":"Glutamate, glutamate receptors, and downstream signaling pathways","volume":"9","author":"SS Willard","year":"2013","journal-title":"International journal of biological sciences"},{"issue":"28","key":"ref33","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2015.447","article-title":"Glutaminolysis as a target for cancer therapy","volume":"35","author":"L Jin","year":"2016","journal-title":"Oncogene"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","article-title":"Glutaminolysis: A Hallmark of Cancer Metabolism","volume":"19","author":"L Yang","year":"2017","journal-title":"Annual review of biomedical engineering"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041200","article-title":"Metabolic Features of Multiple Myeloma","volume":"19","author":"C El Arfani","year":"2018","journal-title":"International journal of molecular sciences"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2007.04.017","article-title":"Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism","volume":"91","author":"DE Wilcken","year":"2007","journal-title":"Molecular genetics and metabolism"},{"issue":"11","key":"ref37","first-page":"860","article-title":"Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure","volume":"98","author":"MN Zairis","year":"2012","journal-title":"Heart (British Cardiac Society)"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12944-015-0070-x","article-title":"Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases","volume":"14","author":"A Raynor","year":"2015","journal-title":"Lipids in health and disease"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0202045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T08:45:43Z","timestamp":1693817143000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0202045"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,10]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0202045","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,10]]}}}